Inventor · disambiguated record
Stanislaw J. Kaczmarczyk
Also filed as: KACZMARCZYK STANISLAW J · KACZMARCZYK STANISLAW JAN
6 granted patents·2 pending applications·39 citations·filing 2013–2023
81Inventor score
Files withUS HEALTH4THE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES2THE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES2
Top patents by PatentIndex Score
8 records- 0194US10040830B2Methods and compositions for protein deliveryUS HEALTH·Filed 2016·Granted Aug 7, 2018·18 cites·20 claims
- 0292US11718861B2Cancer immunotherapy by delivering class II MHC antigens using a VLP-repliconTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2020·Granted Aug 8, 2023·2 cites·10 claims
- 0392US10538743B2Delivery of packaged RNA to mammalian cellsUS HEALTH·Filed 2016·Granted Jan 21, 2020·6 cites·7 claims
- 0491US10577397B2Methods and compositions for protein deliveryTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2018·Granted Mar 3, 2020·10 cites·18 claims
- 0585US9506041B2Delivery of packaged RNA to mammalian cellsUS HEALTH·Filed 2013·Granted Nov 29, 2016·3 cites·8 claims
- 0679US12049639B2Cancer immunotherapy by delivering class II MHC antigens using a VLP-repliconTHE USA AS REPRESENTED BY THE SEC DEP OF HEALTH AND HUMAN SERVICES·Filed 2023·Granted Jul 30, 2024·0 cites·15 claims
- 0768US2020102545A1Delivery of packaged rna to mammalian cellsTHE USA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES·Filed 2019·Application pending·0 cites
- 0864US2016312242A1Cancer immunotherapy by delivering class ii mhc antigens using a vlp-repliconUS HEALTH·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stanislaw J. Kaczmarczyk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →